as on November 5, 2025 at 2:29 am IST
Day's Low
Day's High
0.44%
Downside
2.22%
Upside
52 Week's Low
52 Week's High
6.71%
Downside
38.94%
Upside
Check Bristol-myers Squibb Co. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$92.8B
EPS (TTM)
6.5489
Dividend Yield
4.67%
Quarterly Earnings Growth YOY
0.81%
PE Ratio (TTM)
15.35
Industry PE ratio
19.200384615384614
PEG Ratio
2.2562
EBITDA
19.2B
Revenue (TTM)
48.0B
Profit Margin
12.57%
Return On Equity TTM
33.78%
Track how Bristol-myers Squibb Co. P/E has moved over time to understand its valuation trends.
Bristol-myers Squibb Co. in the last 5 years
Lowest (7.05x)
September 30, 2025
Today (15.35x)
November 5, 2025
Industry (19.20x)
November 5, 2025
Highest (54.19x)
March 31, 2024
Today’s Price to Earnings Ratio: 15.35x
Compare market cap, revenue, PE, and other key metrics of Bristol-myers Squibb Co. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| HOLD | $92.8B | -28.49% | 15.35 | 12.57% | |
| BUY | $802.4B | 523.19% | 43.86 | 30.99% | |
| BUY | $374.4B | 130.43% | 161.8 | 4.00% | |
| BUY | $448.8B | 33.7% | 17.98 | 27.26% | |
| BUY | $217.5B | 34.85% | 12.76 | 35.61% |
The Bristol-myers Squibb Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Bristol-myers Squibb Co. investment value today
Current value as on today
₹86,817
Returns
Returns from Bristol-myers Squibb Co. Stock
Dollar Returns*
₹5,351 (+5.35%)
Based on 31 analysts
32.26%
Buy
64.52%
Hold
3.23%
Sell
Based on 31 analysts, 64.52% of analysts recommend a 'HOLD' rating for Bristol-myers Squibb Co.. Average target price of $53.29
Get share price movements and forecasts by analysts on Bristol-myers Squibb Co..
What analysts predicted
14.47%UPSIDE
Target Price
$53.29
Current Price
$45.58
Analyzed by
31 Analysts
Target
$53.29
Bristol-myers Squibb Co. target price $53.29, a slight upside of 14.47% compared to current price of $45.58. According to 31 analysts rating.
Investment in Bristol-myers Squibb Co. Shares on INDmoney has grown by 51.16% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:51.16%Â versus previous 30 day period
Search interest for Bristol-myers Squibb Co. Stock has increased by 19% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:19%Â versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 30 October
Thu, 08:02 PM
-Bristol-Myers reported Q3 adjusted EPS of $1.63, beating estimates, and raised annual revenue guidance to $47.5-$48 billion.
Thu, 10:25 PM
-Bristol-Myers shares climbed 5% after Q3 results topped Wall Street expectations and raised full-year guidance.
Thu, 10:50 PM
-Bristol-Myers raised its 2025 earnings guidance and reported strong Q3 results, driven by growth portfolio performance.
Today's Timeline - 30 October
Fri, 00:25 AM
-Bristol-Myers reported Q3 revenues of $12.22 billion, exceeding estimates, and raised 2025 sales guidance to $47.5-$48 billion.
Fri, 01:06 AM
-Bristol-Myers Squibb shares rose 4.3% after Q3 results beat expectations and full-year sales forecast was raised.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, BMY stock has moved up by 7.0%
Profit Spike
![]()
Bristol-Myers Squibb Co. has shown strong profit performance, with net profit increasing for the last two quarters. It rose from $1.31 billion to $2.20 billion, reflecting an average increase of 40.5% each quarter.
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 18.0% return, outperforming this stock by 36.5%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 9.0% return, outperforming this stock by 51.1%
Revenue Fall
![]()
Bristol-Myers Squibb Co. has experienced a decline in revenue over the last two quarters. The revenue decreased from $12.26 billion to $12.22 billion, reflecting an average decrease of 0.4% per quarter.
| Organisation | Bristol-myers Squibb Co. |
| Headquarters | Route 206 & Province Line Road, Princeton, NJ, United States, 08543 |
| Industry | Health Technology |
| CEO | Dr. Christopher S. Boerner Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Christopher S. Boerner Ph.D. | CEO & Chairman |
Mr. David V. Elkins | Executive VP & CFO |
Ms. Karin Shanahan | Executive VP, Chief Supply Chain & Operations Officer |
Bristol-myers Squibb Co. share price today is $45.58 as on at the close of the market. Bristol-myers Squibb Co. share today touched a day high of $46.59 and a low of $45.38.
Bristol-myers Squibb Co. share touched a 52 week high of $63.33 on and a 52 week low of $42.52 on . Bristol-myers Squibb Co. stock price today i.e. is closed at $45.58,which is 28.03% down from its 52 week high and 7.20% up from its 52 week low.
Bristol-myers Squibb Co. market capitalisation is $0.09T as on .
Indian investors can start investing in Bristol-myers Squibb Co. (BMY) shares with as little as ₹88.615 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.15 in Bristol-myers Squibb Co. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Bristol-myers Squibb Co. share’s latest price of $45.58 as on November 5, 2025 at 2:29 am IST, you will get 0.2194 shares of Bristol-myers Squibb Co.. Learn more about
fractional shares .
Bristol-myers Squibb Co. stock has given -28.49% share price returns and 20.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?